BG Medicine Inc. (OTCMKTS:BGMD – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. BG Medicine shares last traded at $0.00, with a volume of 0 shares.
BG Medicine Price Performance
About BG Medicine
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Read More
- Five stocks we like better than BG Medicine
- How to Invest in Insurance Companies: A Guide
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- What is a Special Dividend?
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- What is the Dogs of the Dow Strategy? Overview and Examples
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
